As biopharma companies rapidly change their focus, they may lack the laboratory space, instrumentation, and the scientific knowledge to support biologics research.
Paul Denny-Gouldson
Advertisement
Articles by Paul Denny-Gouldson
Advertisement
Latest Updated Articles
Barriers and Solutions to Effective External Collaboration in BiopharmaPublished: October 15th 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
3
BioPharm Weekly News Roundup—Week of Nov. 24, 2025
4
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
5
